e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of obstructive lung disease on mosaic attenuation patern in CTEPH patient
E. Eryuksel, B. Yildizeli, C. Cimsit, S. Olgun Tandogdu, S. Karakut (Istanbul, Turkey)
Source:
Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Session:
Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Session type:
Thematic Poster Session
Number:
2600
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Eryuksel, B. Yildizeli, C. Cimsit, S. Olgun Tandogdu, S. Karakut (Istanbul, Turkey). Effect of obstructive lung disease on mosaic attenuation patern in CTEPH patient. Eur Respir J 2013; 42: Suppl. 57, 2600
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Imaging of complicated pneumonia: what is new?
Emerging classes of drugs for the treatment of obstructive lung disease
Related content which might interest you:
Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Systemic vascular function in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Pulmonary hypertension in COPD: results from the ASPIRE registry
Source: Eur Respir J 2013; 41: 1292-1301
Year: 2013
Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Regional ventilatory defects in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2006 - COPD: imaging and computer applications
Year: 2006
Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Structural brain changes in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
Source: Eur Respir J 2010; 35: 105-111
Year: 2010
Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive lung disease?
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Peculiarities of intracardiac hemodynamics in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Clinical presentations
Year: 2014
Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
A vasomotor form of the endothelial dysfunction of the microvasculature in patients with a chronic obstructive pulmonary disease, and in combination with the pulmonary embolism
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
microRNA profile in COPD patients with and without pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Mechanisms of ECG changes in chronic obstructive pulmonary disease
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Pulmonary hypertension in patients with COPD
Source: Eur Respir Mon 2012; 57: 138-147
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept